Treatment of Enterococcus faecalis Bacteremia
For blood cultures positive for Enterococcus faecalis, start ampicillin 2 g IV every 4 hours plus gentamicin 3 mg/kg/day IV in 3 divided doses, pending susceptibility results. 1, 2
Initial Empiric Therapy
- Ampicillin is the gold standard first-line agent for E. faecalis because most strains (97%) remain ampicillin-susceptible, unlike E. faecium which has intrinsic penicillin resistance 2
- Add gentamicin for synergistic bactericidal activity in serious bloodstream infections 1
- Target gentamicin peak levels of 3-4 μg/mL and trough <1 μg/mL 1
Duration of Therapy Based on Source
For uncomplicated bacteremia without endocarditis:
- Treat for 10-14 days 3
If endocarditis is present or suspected:
- Native valve: 4-6 weeks depending on symptom duration before diagnosis (4 weeks if <3 months of symptoms, 6 weeks if ≥3 months) 1
- Prosthetic valve: minimum 6 weeks 1
Alternative Regimens When Standard Therapy Cannot Be Used
For patients with penicillin allergy (documented by skin testing):
- Vancomycin 30 mg/kg/day IV in 2 divided doses (target trough 10-20 μg/mL) plus gentamicin 3 mg/kg/day for 6 weeks 1
- Note: Ampicillin-gentamicin is superior to vancomycin-gentamicin and has lower nephrotoxicity/ototoxicity risk 1
- Consider penicillin desensitization for true life-threatening infections requiring optimal therapy 4
For high-level aminoglycoside resistance (HLAR):
- Ampicillin 200 mg/kg/day IV in 4-6 divided doses PLUS ceftriaxone 2 g IV every 12 hours for 6 weeks 1
- This double β-lactam regimen avoids aminoglycoside toxicity and is equally effective 1
- The ampicillin-ceftriaxone combination showed no nephrotoxicity versus 23% with ampicillin-gentamicin 1
For streptomycin-susceptible, gentamicin-resistant strains:
- Ampicillin 2 g IV every 4 hours plus streptomycin 15 mg/kg/day IV or IM in 2 divided doses (target peak 20-35 μg/mL, trough <10 μg/mL) 1
- Avoid streptomycin if creatinine clearance <50 mL/min due to irreversible ototoxicity risk 1
For β-lactamase-producing E. faecalis (rare):
- Ampicillin-sulbactam 3 g IV every 6 hours plus gentamicin 1
Critical Monitoring Parameters
- Renal function and aminoglycoside levels must be monitored closely, especially in elderly patients (median age 70 years in major trials) 1
- Consider shortening gentamicin to 2 weeks in patients with baseline renal impairment (creatinine clearance 30-50 mL/min) to reduce nephrotoxicity 1
- Monitor vancomycin troughs if used (target 10-20 μg/mL) 1
Common Pitfalls to Avoid
- Never use cephalosporins alone for enterococcal coverage—they have no intrinsic activity against enterococci 2
- Do not assume E. faecium has the same susceptibility as E. faecalis—E. faecium requires vancomycin or linezolid due to intrinsic ampicillin resistance 2
- Do not empirically use vancomycin for E. faecalis when ampicillin can be used—ampicillin is superior and vancomycin should be reserved for documented β-lactam allergy 2
- Verify susceptibilities when available and adjust therapy accordingly 2
When to Suspect Endocarditis
- Obtain infectious disease and cardiology consultation if bacteremia persists >72 hours, patient has prosthetic valve material, or has new cardiac murmur 1
- Echocardiography (transesophageal preferred) should be performed to rule out endocarditis in persistent bacteremia 1
- E. faecalis bacteremia carries 11% mortality but can reach 50% in severely ill patients 5